IRIS
CERNARO, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.265
EU - Europa 1.940
AS - Asia 625
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 4
Totale 4.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.265
IE - Irlanda 721
SE - Svezia 592
CN - Cina 477
IT - Italia 237
PL - Polonia 118
DE - Germania 80
IN - India 72
FI - Finlandia 65
SG - Singapore 62
GB - Regno Unito 48
BE - Belgio 23
CZ - Repubblica Ceca 16
FR - Francia 16
VN - Vietnam 10
UA - Ucraina 8
AU - Australia 5
EU - Europa 5
NL - Olanda 5
AT - Austria 3
TR - Turchia 3
BR - Brasile 2
ES - Italia 2
LV - Lettonia 2
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
KR - Corea 1
MK - Macedonia 1
RU - Federazione Russa 1
Totale 4.844
Salva come PNG Salva come JPEG
Città #
Dublin 721
Chandler 582
Nyköping 340
Beijing 172
Ashburn 141
Warsaw 118
Dearborn 111
Princeton 106
Jacksonville 102
Medford 95
New York 93
Ann Arbor 90
Des Moines 75
Cambridge 72
Jinan 57
Shenyang 48
Messina 46
Bremen 45
Boardman 44
San Mateo 39
Hyderabad 37
Houston 33
Singapore 32
Pune 30
Wilmington 28
Lancaster 27
Catania 22
Nanjing 22
Brussels 21
Hebei 20
Seattle 20
Tianjin 19
Brno 15
Haikou 15
Hangzhou 15
Ningbo 15
Jiaxing 12
Lentini 12
Los Angeles 11
Taizhou 11
Zhengzhou 11
Dong Ket 10
Munich 10
Fuzhou 8
Nanchang 8
Norwalk 8
Siracusa 8
Cosenza 7
Woodbridge 7
Falls Church 6
Rome 6
Guangzhou 5
Sydney 5
Taiyuan 5
Cagliari 4
Carlentini 4
Changsha 4
Hefei 4
Nottingham 4
Palermo 4
San Giovanni La Punta 4
Augusta 3
Lanzhou 3
Lappeenranta 3
Latina 3
Leawood 3
Mascali 3
Newbury Park 3
Noida 3
Vienna 3
Bergamo 2
Brooklyn 2
Caltagirone 2
Clearwater 2
Fonte Nuova 2
Livorno 2
Miami 2
Milan 2
Paris 2
Saint-Fons 2
Soverato 2
Washington 2
Zonguldak 2
Amsterdam 1
Baton Rouge 1
Bilgi 1
Birmingham 1
Brescia 1
Büdelsdorf 1
Canicattini Bagni 1
Catanzaro 1
Chemnitz 1
Chengdu 1
Chicago 1
Clifton 1
Columbus 1
Cuenca 1
Durrës 1
Foligno 1
Fortaleza 1
Totale 3.716
Salva come PNG Salva come JPEG
Nome #
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 155
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 107
Sclerostin levels in uremic patients: a link between bone and vascular disease 80
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 79
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 77
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 69
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 68
Vascular access for hemodialysis: current perspectives 67
AKI - EXPERIMENTAL MODELS 67
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 66
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 65
A new therapy for kidney injury: regeneration. 64
Before and after preeclampsia: What biomarkers are there? 64
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 64
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 64
Fibrosis, regeneration and cancer: what is the link? 63
Erythropoietin and the truths of science. 63
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 62
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 62
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 61
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 61
Beneficial effects of oral pure caffeine on oxidative stress 61
Auxine: thermodynamic properties, complexing ability and dosage in human serium 61
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 59
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 58
Down with the erythropoietin. Long live the erythropoietin! 58
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 57
[From hyponatremia to tolvaptan] 57
Kidney disease and psoriasis: novel evidences beyond old concepts 57
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 56
Kidney-lung connections in acute and chronic diseases: current perspectives 56
The Myth of Water and Salt: From Aquaretics to Tenapanor 54
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 53
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 53
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 53
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 52
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 52
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 52
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 52
null 52
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 51
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 51
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 50
From water to aquaretics: a legendary route. 50
Unexpected hypercalcemia in a diabetic patient with kidney disease 49
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 49
New options for the management of polycystic kidney disease 49
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 49
Role of Vitamin D Status in Diabetic Patients with Renal Disease 49
Nephro-oncology: a link in evolution 48
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 48
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 47
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 47
ERYTHROPOIETIN EXERTS A RENOPROTECTIVE ACTION IN AN EXPERIMENTAL MODEL OF ZEBRAFISH (DANIO RERIO) AFTER ADMINISTRATION OF GENTAMICIN 47
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 47
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 46
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 46
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 46
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 44
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 44
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 43
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 43
Regenerative medicine: does Erythropoietin have a role? 43
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 43
Renal biopsy: Still a landmark for the nephrologist 42
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 41
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 40
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 40
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 40
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 40
Regeneration and the Plant We have Inside 40
NGAL is a precocious marker of therapeutic response. 39
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 39
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 39
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 39
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 37
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 37
null 37
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 36
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 36
Does Erythropoietin Always Win? 35
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 35
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 35
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 35
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 35
Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report 33
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 33
Research update for articles published in EJCI in 2009 32
Protective role of vitamin d in renal tubulopathies 32
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 30
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 30
Haemodialysis: An Interesting Experimental Model 28
The future of phosphate binders: a perspective on novel therapeutics 27
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 27
New therapeutic strategies under development to halt the progression of renal failure 25
Novel avenues for treating diabetic nephropathy: new investigational drugs 25
New Insights on the Role of Vitamin D in the Progression of Renal Damage 24
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 24
Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology 23
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 22
Totale 4.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020487 0 2 7 14 12 112 59 58 26 142 39 16
2020/2021480 21 22 176 24 96 19 17 9 18 47 14 17
2021/2022840 20 87 21 48 49 8 51 32 7 175 106 236
2022/20232.097 147 234 89 155 165 193 9 126 896 14 53 16
2023/2024616 38 54 27 42 53 197 18 27 5 59 11 85
2024/202558 47 11 0 0 0 0 0 0 0 0 0 0
Totale 5.066